Amgen · 2 months ago
Grad Intern - R&D Pathology Lab
US - California - South San Francisco
Internship
Onsite
Intern
$30/hr - $40/hrAmgen is a pioneering biotech company dedicated to serving patients with serious illnesses. The Grad Intern - R&D Pathology Lab role involves working with the Pathology group to develop and implement specialized tissue-based assays, while maintaining laboratory records and collaborating with mentors on assay optimization.
BiotechnologyHealth CareManufacturingPharmaceutical
No H1B
Responsibilities
Maintain accurate laboratory records and follow all laboratory safety and compliance guidelines
Working with a mentor to perform immunohistochemistry (IHC) staining and contribute to assay optimization and validation
Manage databases and input information, data, and records
Utilize image analysis software to generate quantitative data
Present internship findings at the conclusion of the program
Qualification
Required
18 years or older
Graduated with a bachelor's degree from an accredited college or university
Currently enrolled in an MBA program for an MBA internship OR a Master's program for a Master's internship OR a PharmD program for a PharmD internship OR Ph.D. for a PhD internship from an accredited college or university and completion of the first year of MBA OR Master's OR Pharm D OR Ph.D. program before the internship starts
Enrolled in an accredited college or university following the potential internship
Must not be employed at the time the internship starts
Student must be located in the United States for the duration of the internship
Preferred
Degree concentration(s): Life Sciences, Biology or related field
Strong communication, both written and verbal
Hands-on experience with tissue-based assays, such as immunohistochemistry (IHC), or in situ hybridization (ISH)
Ability to work both independently and collaboratively in a multidisciplinary environment
Company
Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Founded in 1980
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$28.5B2022-12-12Post Ipo Debt· $28.5B
1983-06-17IPO
Leadership Team
Robert Bradway
Chairman and Chief Executive Officer
Jay Bradner
Executive Vice President of R&D, and Chief Scientific Officer
Recent News
2026-01-24
2026-01-22
Company data provided by crunchbase